{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-001134","form_type":"8-K","ticker":"NEPH","cik":"0001196298","company_name":"NEPHROS INC","filed_at":"2023-01-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.080642+00:00","generated_at":"2026-06-20T16:25:38.960047+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Nephros reports preliminary Q4 revenue of $2.6M, FY2022 revenue of $10.0M","bullets":["Q4 2022 net revenue ~$2.6M, down 6% YoY but up 6% sequentially.","Full-year 2022 net revenue ~$10.0M, a 2% decrease from 2021.","Record Active Customer Sites of 1,394 at Q4 end; an all-time high.","Cash balance ~$3.6M; H2 2022 net cash flow improved to -$0.5M from -$2.9M in H1.","Formal Q4 and FY2022 earnings call scheduled for March 8, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-001134","json":"https://secwatch.observer/filing/0001493152-23-001134.json","markdown":"https://secwatch.observer/filing/0001493152-23-001134.md","text":"https://secwatch.observer/filing/0001493152-23-001134.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223001134/0001493152-23-001134-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223001134/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T16:25:38.960047+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"723145792ac997e1ef668d1b840681760db590bc","claim":"NEPHROS INC reported fourth quarter ended December 31, 2022 results: revenue approximately $2.6 million.","evidence_excerpt":"Net revenue for the quarter ended December 31, 2022 is expected to be approximately $2.6 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223001134/0001493152-23-001134-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"approximately $2.6 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"cc521e571e0a5affd449146b79e17db2cc447baa","claim":"NEPHROS INC reported fiscal year ended December 31, 2022 results: revenue approximately $10.0 million.","evidence_excerpt":"Full-year 2022 net revenue is expected to be approximately $10.0 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1196298/000149315223001134/0001493152-23-001134-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended December 31, 2022"},{"label":"Revenue","value":"approximately $10.0 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}